Amyloid imaging
Authors:
- Victor L. VillemagneVVVictor L. Villemagne
- Christopher C. RoweCRChristopher C. Rowe
Open Access
- 1 September 2011
- journal article
- research article
- Published by Elsevier in International Psychogeriatrics
- Vol. 23, S41-S49
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- 18F-THK523: a novel in vivo tau imaging ligand for Alzheimer's diseaseBrain, 2011
- Longitudinal assessment of Aβ and cognition in aging and Alzheimer diseaseAnnals of Neurology, 2011
- Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of agingNeurobiology of Aging, 2010
- O1‐02‐01: Florbetaben for beta‐amyloid brain PET in Alzheimer's disease: Results of a multicenter phase 2 trialAlzheimer's & Dementia, 2010
- IC‐P‐121: Inter‐Ethnic Comparability of Pharmacokinetics of Florbetaben (BAY 94‐9172), a Beta‐Amyloid Imaging PET agent, as a Basis of Global Development of a Diagnostics for Alzheimer's DiseaseAlzheimer's & Dementia, 2010
- 11C-PiB PET studies in typical sporadic Creutzfeldt-Jakob diseaseJournal of Neurology, Neurosurgery & Psychiatry, 2009
- 11 C-PIB PET imaging in Alzheimer disease and frontotemporal lobar degenerationNeurology, 2007
- -amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's diseaseBrain, 2007
- Biomarkers of neurodegeneration for diagnosis and monitoring therapeuticsNature Reviews Drug Discovery, 2007
- Localization of Neurofibrillary Tangles and Beta-Amyloid Plaques in the Brains of Living Patients With Alzheimer DiseaseThe American Journal of Geriatric Psychiatry, 2002